MedTrace Logo

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer

NCT04678583 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-06-13

No results posted yet for this study

Summary

the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).

Conditions

  • Colorectal Liver Metastasis

Interventions

PROCEDURE

Resection of colorectal liver metastases

Comparison of two liver surgery methods

Sponsors & Collaborators

  • German Cancer Research Center

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Jürgen Weitz, Prof Dr med · Department of Gastrointestinal-, Thoracic and Vascular Surgery, University Hospital CGC

  • Nuh Rahbari, Prof Dr med · Allgemein- und Viszeralchirugie, University Hospital Ulm

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04678583 on ClinicalTrials.gov